Drilldown: Medicines - Pharmacopedia

Nav

Choose a table:

Medicines (732)

Medicines > classes

: Benzodiazepine

or Classic Psychedelic

or dissociative

Use the filters below to narrow your results.

Other values:

None (95) · Dalmane (1) · Delysid (historical, Sandoz, withdrawn 1965) (1) · Doral (1) · DXM (1) · DXO (1) · Halcion (1) · Lexotan (1) · Librium (1) · Mogadon (1) · Onfi (1) · ProSom (1) · Restoril (1) · Rohypnol (1) · Serax (1) · Spravato (1) · Tranxene (1) · Versed (1) · Xanax (1)

5-HT2A agonist (26) · GABAA positive allosteric modulator (18) · Potent 5-HT2A agonist (5) · LSD analogue; 5-HT2A agonist (4) · Prodrug of LSD; 5-HT2A agonist (4) · NMDA antagonist (3) · Contains LSA (2) · Contains mescaline (2) · NMDA antagonist; sigma receptor agonist (2)

Other values:

None (111) · Treatment-resistant depression (TRD) in adults, as adjunct to oral antidepressant (FDA-approved March 2019). Depressive symptoms in adults with MDD with acute suicidal ideation or behavior (FDA-approved Aug 2020). (1) · '"`UNIQ--vote-00000069-QINU`"', '"`UNIQ--vote-0000006A-QINU`"', '"`UNIQ--vote-0000006B-QINU`"' (1)

None (111) · 0.25 mg (1) · Induction (TRD): 56 mg intranasal twice weekly × 4 weeks. Maintenance: 56-84 mg once weekly × 4 weeks, then 56-84 mg every 1-2 weeks. For acute suicidality: 84 mg twice weekly × 4 weeks. Administered under medical supervision in REMS-certified site. (1)

None (111) · 0.25 mg, 0.5 mg, 1 mg, 2 mg tablets (immediate-release and orally disintegrating); 0.5 mg, 1 mg, 2 mg, 3 mg extended-release tablets; 1 mg/mL oral concentrate (1) · 28 mg/device (each dose uses 2 devices) (1)

None (111) · 10 mg/d (1) · 84 mg per session (1)

None (110) · Intranasal (under direct medical supervision) (1) · Oral (2)

None (110) · 30-60 min (immediate-release); 1-2 h (extended-release) (1) · 30–60 minutes (1) · Within hours of first administration (1)

None (110) · 6 h (immediate-release); ~11 h (extended-release) (1) · 8–12 hours (1) · Acute effect ~24 hours; cumulative effect builds with repeated dosing (1)

None (110) · 11-13 h (immediate-release); 11-16 h (extended-release) (1) · 3–5 hours (1) · ~7-12 hours (1)

None (110) · 70–90% (oral) (1) · 80-90% oral (1) · ~48% intranasal (1)

None (110) · Avoid; may cause fetal harm (1) · Category D'"`UNIQ--ref-0000006C-QINU`"' (1) · Not established (1)

None (110) · Rx, Schedule III (US). REMS program required. (1) · Schedule I (United States) (1) · Schedule IV (US) (1)

Showing below up to 113 results in range #1 to #113.

1

2

3

4

5

A

B

C

D

E

F

Flurazepam

H

Hawaiian Baby Woodrose

I

Ibogaine

L

M

N

O

P

Q

Quazepam

S

T

X

Xenon

Y

Yopo

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"